Back

High prevalence of undiagnosed abnormal glucose tolerance in patients with acute myocardial infarction in Northern Sweden

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart: pharmacotherapy (2) Diabetes and the Heart ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Gani Bajraktari

University of Prishtina, Pristina (Kosovo Republic of)

5 More presentations in this session

Presentation thumbnail
Comprehensive risk factor control in the early stage of cardiovascular-kidney-metabolic syndrome to mitigate cardiovascular risk
Doctor X. Liu (Guangzhou, CN)
Presentation thumbnail
Association between early-stage systemic metabolic disorder and incident cardiometabolic treatment and cardiovascular hospitalisation in Japanese adults
Assistant Professor T. Adachi (Nagoya, JP)
Abstract Slides
Presentation thumbnail
A lower dose of liraglutide in patients with metabolic syndrome reduces epicardial adipose tissue, increases aerobic capacity and activates AMPK levels in circulating mononuclear cells.
Doctor J. Jalil (Santiago, CL)
Abstract Slides
Presentation thumbnail
Stress hyperglycemia exceeds known diabetes in predicting in-hospital mortality after acute myocardial infarction: An 11-year national study of 13,099 patients
Professor G. Bajraktari (Pristina, XK)
Abstract Slides
Presentation thumbnail
Associations of baseline cumulative and trajectory patterns of the cholesterol HDL glucose index with incident cardiovascular disease
Doctor J. Wei (Xi'an, CN)
Abstract Slides

Access the full session

Session thumbnail
Diabetes and the heart: pharmacotherapy (2)

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Newly diagnosed diabetes at acute myocardial infarction presentation: higher glycemic burden, more multivessel-disease but similar clinical severity to non-diabetics
20 March 2026
thumbnail
Congress Presentation
Time trends in risk factor control and use of secondary preventive medication among patients with myocardial infarction attending cardiac rehabilitation: data from the SWEDEHEART registry 2006-2017
30 August 2020
thumbnail
Congress Presentation
Routine oral glucose tolerance test to improve risk stratification in acute coronary syndrome patients
30 August 2025
thumbnail
Congress Presentation
Comparative effect of 3 different fix-combination antihypertensive treatments in fasting glucose, fasting insulin, OGTT and HbA1c levels, in prediabetic hypertensive patients
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources